Login / Signup

Early achievement of measurable residual disease negativity in the treatment of multiple myeloma as predictor of outcome.

Marion BaumelouAlexandre PayssotCéline RowJessica RacineIngrid LafonJean-Noél BastieSteeve ChevreuxMarie-Lorraine ChrétienMarc MaynadiéDenis CaillotJulien Guy
Published in: British journal of haematology (2022)
Keyphrases
  • multiple myeloma
  • combination therapy
  • replacement therapy